Sustained Placental Growth Factor-2 Treatment Does Not Aggravate Advanced Atherosclerosis in Ischemic Cardiomyopathy

Angiogenic growth factor therapy for ischemic cardiovascular disease carries a risk of stimulating atherosclerotic plaque growth. We evaluated risk benefit ratio of sustained administration of recombinant human placental growth factor (rhPlGF)-2 in mice with advanced atherosclerosis and chronic isch...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of cardiovascular translational research 2017-08, Vol.10 (4), p.348-358
Hauptverfasser:	Wu, Ming, Pokreisz, Peter, Swinnen, Melissa, Caluwe, Ellen, Gillijns, Hilde, Vanden Driessche, Nina, Casazza, Andrea, Verbeken, Erik, Collen, Desire, Janssens, Stefan
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomedical Engineering and Bioengineering Biomedicine Cardiology Human Genetics Medicine Medicine & Public Health Original Article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!